OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Invasive FoxM1 phosphorylated by PLK1 induces the polarization of tumor-associated macrophages to promote immune escape and metastasis, amplified by IFITM1
Rong Xu, Youngjoo Lee, Chang-Hyeon Kim, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 18

Showing 18 citing articles:

Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives
Xiaoli Shi, Xinyi Wang, Wentao Yao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 30

Innate Immune Cells in Tumour Microenvironment: A New Frontier in Cancer Immunotherapy
Changhui Li, Xinyu Yu, Xinyan Han, et al.
iScience (2024) Vol. 27, Iss. 9, pp. 110750-110750
Open Access | Times Cited: 8

STING in Cancer Immunoediting: Modeling Tumor-Immune Dynamics Throughout Cancer Development
Xiao Zhang, Yan Chen, Xi Liu, et al.
Cancer Letters (2025) Vol. 612, pp. 217410-217410
Open Access | Times Cited: 1

METTL1/FOXM1 promotes lung adenocarcinoma progression and gefitinib resistance by inhibiting PTPN13 expression
Wei Peng, Jia Fu, Lijun Zhou, et al.
Cancer Medicine (2024) Vol. 13, Iss. 13
Open Access | Times Cited: 6

Onvansertib exhibits anti-proliferative and anti-invasive effects in endometrial cancer
Nikita Sinha, Xiaochang Shen, Jennifer Haag, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access

APOC1, transcriptionally regulated by FOXM1, promotes M2 macrophage polarization and cervical cancer progression
Qing Chai, Yan Qi, Xiaoyan Nie, et al.
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis (2025) Vol. 830, pp. 111904-111904
Closed Access

A Chimeric Oncolytic Adenovirus Carried by Macrophages for Glioma Immunotherapy
Fansong Tang, Zongliang Zhang, Jianguo Xu, et al.
Research Square (Research Square) (2025)
Closed Access

Histone lactylation in macrophage biology and disease: from plasticity regulation to therapeutic implications
Chuncha Bao, Qing Ma, Xuchao Ying, et al.
EBioMedicine (2024) Vol. 111, pp. 105502-105502
Open Access | Times Cited: 3

Foxm1-mediated transcriptional inactivation of NLRP3 inflammasome promotes immunosuppression in cervical cancer
Weipeng Ji, Yang Jin, Wen G. Jiang
Critical Reviews in Eukaryotic Gene Expression (2024) Vol. 34, Iss. 8, pp. 35-45
Closed Access | Times Cited: 1

Synergistic two-step inhibition approach using a combination of trametinib and onvansertib in KRAS and TP53-mutated colorectal adenocarcinoma
Daeun Kim, Hyun‐Ji Oh, Hyunjin Kim, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 182, pp. 117796-117796
Closed Access | Times Cited: 1

Elucidating the Molecular Mechanisms of Pterostilbene Against Cervical Cancer Through an Integrated Bioinformatics and Network Pharmacology Approach
Xiang Li, Dequan Yu, Qiming Wang, et al.
Chemico-Biological Interactions (2024) Vol. 396, pp. 111058-111058
Closed Access

Linking FOXM1 and PD-L1 to CDK4/6-MEK targeted therapy resistance in malignant peripheral nerve sheath tumors
Joshua J. Lingo, Ellen Voigt, Dawn E. Quelle
Oncotarget (2024) Vol. 15, Iss. 1, pp. 638-643
Open Access

Page 1

Scroll to top